Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating
whether members of the board of directors of Cubist Pharmaceuticals,
Inc. (NASDAQ: CBST) breached their fiduciary duties in connection with
the planned merger of the Company with Merck & Co., Inc. Cubist is
engaged in the research, development, and commercialization of
pharmaceutical products for medical needs in the acute care environment.
for CUBIST PHARMACEUTICALS ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Cubist Pharmaceuticals, Inc. to Merck investment picks